Mc Callion Orla
General Counsel bei ULTIMOVACS ASA
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Mc Callion Orla
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
10
| Holding Company | Pharmaceuticals: Generic | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mc Callion Orla
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Uppsala | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| University of Oslo | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Norwegian School of Economics & Business Administration | College/University | Masters Business Admin Undergraduate Degree | |
| Norwegian University of Science & Technology | College/University | Doctorate Degree Graduate Degree | |
| BI Norwegian Business School | College/University | Graduate Degree Undergraduate Degree | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| Fabritius eiendom AS | Director/Board Member | ||
Profier AS
 Profier AS Real Estate DevelopmentFinance Part of Gjelsten Holding AS, Profier AS is a Norwegian real estate company that has developed over 10,000 homes and 800,000 square meters of commercial and commercial buildings across the country since 1994. The company is based in Asker, Norway. Profier is a nationwide real estate developer that develops and implements its real estate projects from idea to turnaround buildings, with a focus on housing. The company has between 50 and 60 projects under development at all times, with good location, smart floor plans, and quality that are significantly higher than the market usually offers. Profier also offers plots for sale and can develop them into something nice through competent and dedicated employees, good and reliable partners, and very good dialogue with the public. | Real Estate Development | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| CIRCIO HOLDING ASA | Biotechnology | Chairman Founder | |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Key Neurosciences SAS provides research and development services. Its services include product and technology development, fund raising, business and commercial development, and project management. The company was founded in December 2010 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Ulvenveien 90 ANS | Miscellaneous | Director/Board Member | |
| Huj Eiendom AS | Director/Board Member | ||
| ANS Ostre Aker Vei 24 B | Miscellaneous | Director/Board Member | |
| Trollåsveien 8 AS | Director/Board Member | ||
| Østre Rosten Utvikling AS | Director/Board Member | ||
| Ulven Vakant 3 AS | Director/Board Member | ||
| Gasolin Brodlos AS | Director/Board Member | ||
G&A Air AS
 G&A Air AS AirlinesTransportation G&A Air AS owns, operates, and leases airplanes. Its other activities include repairs and maintenance of aircraft park. The company was founded on September 1, 2014 and is headquartered in Oslo, Norway. | Airlines | Chairman | |
| Ulven Vakant AS | Director/Board Member | ||
| Dokka Torg AS | Director/Board Member | ||
| Ulven Vakant 5 AS | Director/Board Member | ||
| Stranden 57 AS | Director/Board Member | ||
| Østre Aker Vei 24 C AS | Director/Board Member | ||
| Bekkestuene Bolig AS | Director/Board Member | ||
| Vestnes Park AS | Director/Board Member | ||
| Ans Kinta | Director/Board Member | ||
| Ulvenveien 92 C ANS | Director/Board Member | ||
| Ulvenveien 91 DA | Director/Board Member | ||
| Stensrød Prosjekt AS | Director/Board Member | ||
| Ulvenveien 96 ANS | Director/Board Member | ||
| Profier Eiendom AS | Director/Board Member | ||
| Bøler Prosjekt AS | Director/Board Member | ||
| Brøløs Torg AS | Director/Board Member | ||
| Vågsgaten Parkering AS | Director/Board Member | ||
| Zita Shipping Ltd. | Director/Board Member | ||
| Bekkestua Eiendomsutvikling AS | Director/Board Member | ||
| Fuglesangen Invest AS | Director/Board Member | ||
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | Biotechnology | Chairman Director/Board Member | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistik
International
| Norwegen | 37 |
| Frankreich | 6 |
| Schweden | 4 |
| Dänemark | 4 |
| Niederlande | 3 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 6 |
| Finance | 3 |
| Commercial Services | 3 |
| Miscellaneous | 3 |
Operativ
| Director/Board Member | 205 |
| Corporate Officer/Principal | 70 |
| Chairman | 52 |
| Chief Executive Officer | 37 |
| Independent Dir/Board Member | 30 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Henrik Schüssler | 89 |
| Alain Munoz | 38 |
| Georges Gemayel | 33 |
| Khalid Islam | 29 |
| Rémi Droller | 29 |
| Bengt Håkan Englund | 18 |
| Matthew Gantz | 16 |
| Anne Hovi Worsøe | 16 |
| Peder Sven Walberg | 15 |
| Carlos de Sousa | 14 |
| Anders Fink Vadsholt | 13 |
| Jónas Einarsson | 12 |
| Kari Grønås | 12 |
| Antonius Berkien | 11 |
| Aitana Peire | 9 |
- Börse
- Insiders
- Mc Callion Orla
- Unternehmensverbindungen
